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One Sentence Summary: Comprehensive heritability analysis of brain phenotypes demonstrates a 59 
clear role for common genetic variation across neurological and psychiatric disorders and 60 
behavioral-cognitive traits, with substantial overlaps in genetic risk. 61 
Abstract: Disorders of the brain exhibit considerable epidemiological comorbidity and frequently share 62 
symptoms, provoking debate about the extent of their etiologic overlap. We quantified the genetic sharing 63 
of 24 brain disorders and 16 phenotypes based on summary statistics from genome-wide association 64 
studies. Psychiatric disorders show substantial sharing of common variant risk, while neurological 65 
disorders appear more distinct from one another. We observe limited evidence of sharing between 66 
neurological and psychiatric disorders, but do identify sharing between several quantitative measures and 67 
brain disorders. We also performed extensive simulations to explore power and the impact of diagnostic 68 
misclassification and phenotypic heterogeneity. These results highlight the importance of common 69 
genetic variation as a source of risk for brain phenotypes and the value of heritability-based methods in 70 
understanding their etiology. 71 
Main Text:  72 
The classification of brain disorders has evolved over the past century, reflecting the 73 
medical and scientific communities’ best assessments of the presumed root causes of clinical 74 
phenomena such as behavioral change, loss of motor function, spontaneous movements or 75 
alterations of consciousness. A division between neurology and psychiatry developed, with the 76 
more directly observable phenomena (such as the presence of emboli, protein tangles, or unusual 77 
electrical activity patterns) generally defining the neurological disorders(1). Applying modern 78 
methods to understand the genetic underpinnings and categorical distinctions between brain 79 
disorders may be helpful in informing next steps in the search for the biological pathways that 80 
underlie their pathophysiology(2, 3). 81 
In general, brain disorders (here excepting those caused by trauma, infection or cancer) 82 
show substantial heritability from twin and family studies (4). Epidemiological and twin studies 83 
have explored patterns of phenotypic overlaps(5-7), and substantial comorbidity has been 84 
reported for many pairs of disorders, including bipolar disorder-migraine(8), stroke-major 85 
depressive disorder(MDD)(9), epilepsy-autism spectrum disorders (ASD) and epilepsy-attention 86 
deficit hyperactivity disorder (ADHD)(10). Furthermore, neurological and psychiatric research 87 
has shown that mutations in the same ion channel genes confer pleiotropic risk for multiple 88 
distinct brain phenotypes(11-13). Recently, genome-wide association studies (GWAS) have 89 
demonstrated that individual common risk variants show overlap across traditional diagnostic 90 
3 
 
boundaries (14, 15), and that disorders like schizophrenia, MDD and bipolar disorder can have 91 
strong genetic correlations(16).  92 
GWAS have also demonstrated that common genetic variation substantially contributes 93 
to the heritability of brain disorders. In most cases, this occurs via many common variants with 94 
small risk effects, as has been the case with Alzheimer’s disease(17), bipolar disorder(18), 95 
migraine(19), Parkinson’s disease(20), and schizophrenia(21). In addition to locus discovery, 96 
larger sample sizes enable analyses of shared genetic influences, to improve our understanding of 97 
the degree of distinctiveness of brain disorders(22). Using recently developed heritability-based 98 
methods(23) we can now extend our evaluation of the nature of these diagnostic boundaries and 99 
explore the extent of shared common variant genetic influences across a wide set of neurological 100 
and psychiatric phenotypes.  101 
 102 
Study design 103 
We formed the Brainstorm consortium, a collaboration among GWAS meta-analysis 104 
consortia of 24 disorders (see Data sources), to perform the first comprehensive heritability and 105 
correlation analysis of brain disorders. The study sample consists of 212,367 brain disorder cases 106 
and 647,979 controls (Table 1), including every common brain disorder for which we could 107 
identify a meta-analysis consortium and reflecting the respective current diagnostic gold 108 
standards. This includes at least the most common representative in each ICD-10 block in F20-109 
59 (mental and behavioral disorders) and G20-G47 (diseases of the central nervous system). Also 110 
included are 1,113,280 samples for 12 “behavioral-cognitive” phenotypes (n=666,178) chosen 111 
for being traditionally viewed as brain-related, and four “additional” phenotypes (n=447,102), 112 
selected to represent known, well-delineated etiological processes (e.g. immune disorders 113 
[Crohn’s disease] and vascular disease [coronary artery disease]; Table 2).  114 
GWAS summary statistics for the 40 disorders and phenotypes were centralized and 115 
underwent uniform quality control and processing(24). We generated European-only meta-116 
analyses for each disorder to avoid potential biases arising from ancestry differences, as many of 117 
the brain disorder datasets included sample sets from diverse ancestries. We have recently 118 
developed a novel heritability estimation method, linkage disequilibrium score regression 119 
(LDSC)(23), which was used to calculate heritability estimates and correlations, as well as to 120 
estimate their statistical significance from block jack-knife-based standard errors. Heritability for 121 
binary disorders and phenotypes was transformed to liability-scale. We further performed a 122 
weighted-least squares regression analysis to evaluate whether differences relating to study 123 
makeup (such as sample size) were correlated with the magnitude of the correlation estimates. 124 
We also performed a heritability partitioning analysis using stratified LD score regression to 125 
examine whether the observed heritability was enriched in any tissue-specific regulatory 126 
partitions of the genome, using the ten top-level tissue-type and 53 functional partitions from 127 
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Finucane et al. (25). Finally, simulated phenotype data was generated under several different 128 
scenarios by permuting the 120,267 genotyped individuals from the UK Biobank (24) to both 129 
evaluate power and aid in interpreting the results (see Supplementary Text). 130 
 131 
Heritability and correlations among brain disorders 132 
We observed a similar range of heritability estimates among the disorders and the 133 
behavioral-cognitive phenotypes (Fig. S1A-B and Table S1, S2), roughly in line with previously 134 
reported estimates in smaller datasets (see Table S3 and Supplementary Text). Three ischemic 135 
stroke subtypes (cardioembolic, large-vessel disease and small-vessel disease) as well as the 136 
“agreeableness” personality measure from NEO Five-Factor Inventory(26) had insufficient 137 
evidence for additive heritability for robust analysis and were excluded from further 138 
analysis(24). We did not observe a correlation between heritability estimates and factors relating 139 
to study makeup (Table S4; Fig S1C-F).  140 
In expanding on the number of pairwise comparisons in brain disorders, we observed 141 
widespread sharing across psychiatric disorders (Fig. 1 and S3) beyond those previously reported 142 
(16), but not among neurological disorders. Among the psychiatric disorders, schizophrenia in 143 
particular showed significant genetic correlation with most of the psychiatric disorders. Further, 144 
schizophrenia, bipolar disorder, anxiety disorders, MDD and ADHD each showed a high degree 145 
of correlation to the four others (average rg=0.40; Table S5). Anorexia nervosa, OCD and 146 
schizophrenia also demonstrated significant sharing amongst themselves. Tourette’s syndrome 147 
(TS) was only significantly correlated with OCD and migraine and not with any of the other 148 
disorders. From this analysis, the common variant risk of both ASD and TS appear to be 149 
somewhat distinct from other psychiatric disorders, although with some evidence of correlation 150 
between TS and OCD and between ASD and schizophrenia. The modest power of the ASD and 151 
TS meta-analyses, however, limits the strength of this conclusion.  152 
Neurological disorders revealed greater specificity, and a more limited extent of genetic 153 
correlation than the psychiatric disorders (Fig. 2 and S4, Table S5). Parkinson’s disease, 154 
Alzheimer’s disease, generalized epilepsy and multiple sclerosis showed little to no correlation 155 
with any other brain disorders. Focal epilepsy showed the highest degree of genetic correlation 156 
among the neurological disorders (average rg =0.46, excluding other epilepsy datasets), though 157 
none were significant, reflecting the relatively modest power of the current focal epilepsy meta-158 
analysis. However, the modest heritability and the broad pattern of sharing observed for focal 159 
epilepsy may be consistent with considerable heterogeneity and potentially even diagnostic 160 
misclassification across a range of neurological conditions.  161 
In the cross-category correlation analysis, the overall pattern is consistent with limited 162 
sharing across the included neurological and psychiatric disorders (Fig. 3; average rg=0.03). The 163 
only significant cross-category correlations were with migraine, suggesting it may share some of 164 
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its genetic architecture with psychiatric disorders; migraine-ADHD (rg=0.26, p=8.81 x 10-8), 165 
migraine-TS (rg=0.19, p=1.80 x 10-5), and migraine-MDD (rg=0.32, p=1.42 x 10-22 for all 166 
migraine, rg=0.23, p=5.23 x 10-5 for migraine without aura, rg=0.28, p=1.00 x 10-4 for migraine 167 
with aura). 168 
We observed several significant genetic correlations between the behavioral-cognitive or 169 
additional phenotypes and brain disorders (Fig. 4 and S5, Table S6). Years of education showed 170 
a significant correlation to each psychiatric disorder (negative for ADHD, anxiety disorders, 171 
MDD and TS; positive for the others), while five neurological phenotypes (Alzheimer’s disease 172 
and the four “vascular” phenotypes, intracerebral hemorrhage, all and early-onset stroke and 173 
migraine) showed a significant negative correlation (Fig. S6; correlations with bipolar 174 
disorder(23), Alzheimer’s disease and schizophrenia have been previously reported(27)). Among 175 
the personality measures, significant positive correlations were observed for neuroticism (anxiety 176 
disorders, migraine, migraine without aura and OCD; Fig. S7), depressive symptoms (ADHD, 177 
anxiety disorder, bipolar disorder, MDD, and schizophrenia) and subjective well-being (anxiety 178 
disorder, bipolar disorder, MDD, as well as replicating the previously reported correlation 179 
between neuroticism with both MDD and schizophrenia(28)). For smoking-related measures, the 180 
only significant genetic correlations were to never/ever smoked (MDD: rg=0.33, p=3.10 x 10-11 181 
and ADHD: rg=0.37, p=3.15 x 10-6).  182 
Among the additional phenotypes, the two diseases chosen as examples of disorders with 183 
well-defined etiologies had different results: Crohn’s disease, representing immunological 184 
pathophysiology, showed no correlation with any of the study phenotypes, while the phenotype 185 
representing vascular pathophysiology (coronary artery disease) showed significant correlation 186 
to MDD (rg=0.19, p=8.71 x 10-5) as well as the two stroke-related phenotypes (rg=0.69, p=2.47 x 187 
10-6 to ischemic stroke and rg=0.86, p=2.26 x 10-5 for early-onset stroke), suggesting shared 188 
genetic effects across these phenotype. Significant correlations were also observed for BMI, 189 
which was positively correlated with ADHD and MDD, and negative correlated with anorexia 190 
nervosa (as previously reported with a different dataset(23)) and schizophrenia. 191 
Functional enrichment analysis (Table S7 and S8) replicated the previously reported 192 
central nervous system (CNS) enrichment for schizophrenia and bipolar disorder (here in a larger 193 
dataset compared to the original report (25), but with considerable sample overlap). We also 194 
demonstrated novel significant heritability enrichments to CNS (for generalized epilepsy, MDD, 195 
TS, college attainment, neuroticism, never/ever smoked) and to immune system cells and tissues 196 
(multiple sclerosis). 197 
 198 
Discussion 199 
By integrating and analyzing the current genome-wide association summary statistic data 200 
from consortia of 24 brain disorders, we find that psychiatric disorders broadly share a 201 
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considerable portion of their common variant genetic risk, especially across schizophrenia, 202 
MDD, bipolar disorder, anxiety disorder and ADHD, while neurological disorders are more 203 
genetically distinct. Across categories, psychiatric and neurologic disorders share relatively little 204 
of their common genetic risk, suggesting that multiple different and largely independently 205 
regulated etiological pathways may give rise to similar clinical manifestations (e.g., psychosis, 206 
which manifests in both schizophrenia(29) and Alzheimer’s disease(30)). Except for migraine, 207 
which appears to share genetic architecture with psychiatric disorders, the existing clinical 208 
delineation between neurology and psychiatry is recapitulated at the level of common variant 209 
risk for the studied disorders.  210 
Given that the broad and continuous nature of psychiatric disorder spectra in particular 211 
has been clinically recognized for a long time(31-33), we evaluated whether diagnostic 212 
misclassification (given that genetic correlations are always a function of the underlying 213 
ascertained phenotypes) could cause the observed correlations. For example, substantial numbers 214 
of cases progressing through multiple diagnoses over lifetime or some the diagnostic boundaries 215 
between some phenotype pairs being particularly porous to misclassification, congruent with the 216 
clinical controversies in classification, could give rise to the appearance of correlation. Previous 217 
work(34) suggests that even substantial misclassification is likely insufficient to introduce high 218 
levels of genetic correlation. We expanded on this work by performing a series of simulations 219 
across a variety of scenarios. These simulations demonstrate that reasonable levels of 220 
misclassification or changes in the exact level of heritability appear unlikely to induce substantial 221 
changes in the estimated genetic correlation (Fig. S8, S9, Table S9 and Supplementary Text), 222 
though the lower resulting heritability (Fig. S8A) would decrease the power to estimate the 223 
genetic overlap (Fig S10). Further, such evidence of genetic overlap is unlikely to appear in the 224 
absence of underlying genetic correlation (Table S10), as it is apparent that very high (up to 225 
79%) degree of misclassification would be required to produce the observed correlations in the 226 
absence of any true genetic correlation. Therefore, the observed correlations suggest true sharing 227 
of a substantial fraction of the common variant genetic architecture among psychiatric disorders 228 
as well as between behavioral-cognitive measures and brain disorders.  229 
The high degree of genetic correlation among the psychiatric disorders adds further 230 
evidence that current clinical diagnostics do not reflect the underlying genetic etiology of these 231 
disorders, and that genetic risk factors for psychiatric disorders do not respect clinical diagnostic 232 
boundaries. This suggests an interconnected nature for their genetic etiology, in contrast to 233 
neurological disorders, and underscores the need to refine psychiatric diagnostics. This study 234 
may provide important ‘scaffolding’ to support a new research framework for investigating 235 
mental disorders, incorporating many levels of information to understand basic dimensions of 236 
brain function, such as through the National Institute of Mental Health’s RDoC initiative.  237 
The observed positive genetic correlations are consistent with a few different scenarios. 238 
For example, rg may reflect the existence of some portion of common genetic risk factors 239 
conferring equal risks to multiple disorders where other distinct additional factors contribute to 240 
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the eventual clinical presentation. The presence of significant genetic correlation may also reflect 241 
the phenotypic overlap between any two disorders; for example, the sharing between 242 
schizophrenia and ADHD might reflect underlying difficulties in executive functioning, which 243 
are well-established in both disorders(35). Similarly, the sharing between anorexia nervosa, OCD 244 
and schizophrenia may reflect a shared mechanism underlying cognitive biases that extend from 245 
overvalued ideas to delusions. Another scenario is that a heritable intermediate trait confers risk 246 
to multiple outcomes, thereby giving rise to the genetic correlation, as the genetic influences on 247 
this trait will be shared for both outcomes (e.g., obesity as a risk factor for both type 2 diabetes 248 
and coronary artery disease), or even that the majority common genetic effects are shared 249 
between a pair of traits, but each individual effect may confer different degrees of risk and lead 250 
to different aggregate genetic risk profiles. While a combination of these is likely, it will become 251 
increasingly feasible to evaluate these overlaps at the locus level in the future as more genome-252 
wide significant loci are identified. 253 
The low correlations observed across neurological disorders suggest that the current 254 
classification reflects relatively specific genetic etiologies, although the limited sample size for 255 
some of these disorders and lack of inclusion of disorders conceived as “circuit-based” in the 256 
literature, such as restless legs syndrome, sleep disorders and possibly essential tremor, 257 
constrains the generalizability of this conclusion. Generally, this analysis recapitulates the 258 
current understanding of the relatively distinct primary etiology underlying these disorders; 259 
degenerative disorders (such as Alzheimer’s and Parkinson’s diseases) would not be expected a 260 
priori to share their polygenic risk profiles with a neuro-immunological disorder (like multiple 261 
sclerosis) or neurovascular disorder (like ischemic stroke). Similarly, we see limited evidence for 262 
the reported co-morbidity between migraine with aura and ischemic stroke(36) (rg=0.29, 263 
p=0.099); however, the standard errors of this comparison are too high to draw strong 264 
conclusions. At the disorder subtype level, migraine with and without aura (rg=0.48, p=1.79 x 10-265 
5) show substantial genetic correlation, while focal and generalized epilepsy (rg=0.16, p=0.388) 266 
show much less.  267 
The few significant correlations across neurology and psychiatry, namely between 268 
migraine and ADHD, MDD and TS, suggest modest shared etiological overlap across the 269 
neurology/psychiatry distinction. The co-morbidity of migraine with MDD and ADHD has been 270 
previously reported in epidemiological studies (37-39), while in contrast, the previously reported 271 
co-morbidity between migraine and bipolar disorder seen in epidemiological studies (40) was not 272 
reflected in our estimate of genetic correlation (rg=-0.03, p=0.406).   273 
Several phenotypes show only very low-level correlations with any of the other studied 274 
disorders and phenotypes, despite large sample size and robust evidence for heritability, 275 
suggesting their common variant genetic risk may largely be unique. Alzheimer’s disease, 276 
Parkinson’s disease, and multiple sclerosis show extremely limited sharing with the other 277 
phenotypes and with each other. Neuroinflammation has been implicated in the pathophysiology 278 
of each of these conditions(41-43), as it has for migraine(44) and schizophrenia(45), but no 279 
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considerable shared heritability was observed with either of those conditions nor with Crohn’s 280 
disease. While this observation does not preclude shared neuroinflammatory mechanisms in 281 
these disorders, it does suggest that on a large scale, common variant genetic influences on these 282 
inflammatory mechanisms are not shared between the disorders. Further, we only observed 283 
significant enrichment of heritability to immunological cells and tissues in multiple sclerosis, 284 
showing that inflammation-specific regulatory marks in the genome do not show overall 285 
enrichment for common variant risk for either Alzheimer’s or Parkinson’s diseases (though this 286 
does not preclude the effects of specific, non-polygenic neuroinflammatory mechanisms(46)). 287 
Among psychiatric disorders, ASD and TS showed a similar absence of correlation with other 288 
disorders, although this could reflect small sample sizes. 289 
Analysis of the Big Five personality measures suggests that the current sample sizes for 290 
personality data are now starting to be sufficiently large for correlation testing; neuroticism, 291 
which has by far the largest sample size, shows a number of significant correlations. Most 292 
significant of these was to MDD (rg=0.737, p=5.04 x 10-96), providing further evidence for the 293 
link between these phenotypes, reported previously with polygenic risk scores(47) and twin 294 
studies(48, 49); others included schizophrenia, anxiety disorders, migraine, migraine without 295 
aura, and OCD (Table S6). Further, the observation of strong correlation between MDD and 296 
anxiety disorders together with their remarkably strong and similar patterns of correlation 297 
between each of these disorders and the dimensional measures of depressive symptoms, 298 
subjective well-being, and neuroticism suggests that they all tag a fundamentally similar 299 
underlying etiology. The novel significant correlation between coronary artery disease and MDD 300 
supports the long-standing epidemiological observation of a link between MDD and CAD(50), 301 
while the observed correlation between ADHD and smoking initiation (rg=0.374, p=3.15 x 10-6) 302 
is consistent with the epidemiological evidence of overlap(51) and findings from twin 303 
studies(52), supporting the existing hypothesis that impulsivity inherent in ADHD may drive 304 
smoking initiation and potentially dependence (though other explanations, such as reward system 305 
dysfunction would fit as well). 306 
For the neurological disorders, five (Alzheimer’s disease, intracerebral hemorrhage, 307 
ischemic and early-onset stroke, and migraine) showed significant negative genetic correlation to 308 
the cognitive measures, while a further two (epilepsy and focal epilepsy) showed moderate 309 
negative genetic correlation (Fig. S6). For Alzheimer’s disease, poor cognitive performance in 310 
early life has been linked with increased risk for developing the disorder in later life(53), but to 311 
our knowledge no such connection has been reported for the other phenotypes. ADHD, anxiety 312 
disorders and MDD show a significant negative correlation to cognitive and education attainment 313 
measures, while the remaining five of the eight psychiatric disorders (anorexia nervosa, ASD, 314 
bipolar disorder, OCD, and schizophrenia) showed significant positive genetic correlation with 315 
one or more cognitive measures. These results strongly suggest the existence of a link between 316 
cognitive performance already in early life and the genetic risk for both psychiatric and 317 
neurological brain disorders. The basis of the genetic correlations between education, cognition 318 
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and brain disorders may have a variety of root causes including, indexing performance 319 
differences based on behavioral dysregulation (e.g., ADHD relating to attentional problems 320 
during cognitive tests) or may reflect ascertainment biases in certain disorders conditional on 321 
impaired cognition (e.g., individuals with lower cognitive reserve being more rapidly identified 322 
for Alzheimer’s disease).  323 
BMI shows significant positive genetic correlation to ADHD, consistent with a meta-324 
analysis linking ADHD to obesity(54), and negative genetic correlation with anorexia nervosa, 325 
OCD and schizophrenia. These results connect well with the evidence for enrichment of BMI 326 
heritability in CNS tissues(25) and that many reported signals suggest neuronal involvement(55); 327 
this may also provide a partial genetic explanation for lower BMI in anorexia nervosa patients 328 
even after recovery(56). Given that no strong correlations were observed between BMI and any 329 
of the neurological phenotypes, it is possible to hypothesize that BMI’s brain-specific genetic 330 
architecture is more closely related to behavioral phenotypes. Ischemic stroke and BMI show 331 
surprisingly little genetic correlation in this analysis (rg=0.07, p=0.26), suggesting that although 332 
BMI is a strong risk factor for stroke(57), there is little evidence for shared common genetic 333 
effects. These analyses also suggest that the reported reduced rates of cardiovascular disease in 334 
individuals with histories of anorexia nervosa (58, 59) are due to BMI-related effects; with the 335 
limited evidence of genetic correlation of anorexia nervosa with intracerebral hemorrhage, 336 
ischemic stroke, early-onset stroke and coronary artery disease, these results suggest that any 337 
lower cardiovascular mortality is more likely due to direct BMI-related effects rather than  338 
shared common genetic risk variants.  339 
Broadly it is apparent that the current clinical boundaries for the studied psychiatric 340 
phenotypes do not appear to reflect distinct underlying pathogenic processes based on the genetic 341 
evidence, while in contrast, the studied neurological disorders show much greater genetic 342 
specificity. Although it is important to emphasize that while some disorders are under-343 
represented here (e.g. personality disorders in psychiatry and circuit-based disorders such as 344 
restless leg syndrome in neurology), these results clearly demonstrate the limited evidence for 345 
widespread common genetic risk sharing between psychiatric and neurological disorders, while 346 
on the other hand providing strong evidence for links between them and behavioral-cognitive 347 
measures. We highlight the need for some degree of restructuring of psychiatric nosology and 348 
that genetically informed analyses may provide a good basis for such activities, consistent with 349 
the historical knowledge from twin- and family-based results. Further elucidation of individual 350 
disorders and their genetic overlap, especially as distinct loci map onto a subset of disorders and 351 
etiological processes, may form the basis for either defining new clinical phenotypes or support a 352 
move to a more continuous view of psychiatric phenotypes. Ultimately, such developments give 353 
hope for reducing diagnostic heterogeneity and eventually improving the diagnosis and treatment 354 
of psychiatric disorders.  355 
 356 
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 523 
Data sources 524 
Disorder or phenotype – Consortium or dataset identifier – web address: 525 
Psychiatric disorders  526 
ADHD – PGC-ADD2 - http://www.med.unc.edu/pgc/results-and-downloads 527 
Anorexia nervosa – PGC-ED - http://www.med.unc.edu/pgc/results-and-downloads 528 
Anxiety disorder – ANGST - http://www.med.unc.edu/pgc/results-and-downloads 529 
Autism spectrum disorders(16) – PGC-AUT - http://www.med.unc.edu/pgc/results-and-downloads 530 
Bipolar disorder – PGC-BIP2 - http://www.med.unc.edu/pgc/results-and-downloads (soon) 531 
Major depressive disorder – PGC-MDD2 - http://www.med.unc.edu/pgc/results-and-downloads (soon) 532 
OCD – IOCDFGC - https://iocdf.org/ 533 
Schizophrenia(21) – PGC-SCZ2 - http://www.med.unc.edu/pgc/results-and-downloads 534 
Tourette Syndrome – TSAIGC –  http://www.med.unc.edu/pgc/results-and-downloads 535 
 536 
Neurological disorders  537 
Alzheimer's disease(17) – IGAP - http://www.pasteur-lille.fr/en/recherche/u744/igap 538 
Epilepsy and subtypes, focal and generalized(60) – ILAE – http://www.epigad.org/page/show/gwas_index 539 
Intracerebral hemorrhage(61) – ISGC - http://www.strokegenetics.com/ 540 
Ischemic stroke and subtypes (cardioembolic, early-onset, small-vessel and large-vessel)(62) – METASTROKE 541 
dataset of the ISGC – http://www.strokegenetics.com/ 542 
Migraine and subtypes, migraine with and without aura – IHGC – www.headachegenetics.org 543 
Multiple sclerosis(63) – IMSGC - http://eaglep.case.edu/imsgc_web 544 
Parkinson's disease(20) – IPDGC – www.pdgene.org 545 
 546 
Behavioral-cognitive phenotypes 547 
College attainment, years of education(64) – SSGAC – http://www.thessgac.org/data 548 
Childhood cognitive performance(65) – SSGAC – http://www.thessgac.org/data 549 
Extraversion, agreeableness, conscientiousness and openness (26) – GPC – http://www.tweelingenregister.org/GPC/ 550 
Neuroticism, depressive symptoms and subjective well-being (66) – SSGAC - http://www.thessgac.org/data 551 
Never/ever smoked, cigarettes per day(67) - TAG - http://www.med.unc.edu/pgc/results-and-downloads 552 
 553 
Additional phenotypes  554 
BMI(55) – GIANT – https://www.broadinstitute.org/collaboration/giant 555 
Height(68) – GIANT – https://www.broadinstitute.org/collaboration/giant 556 
 557 
Crohn’s disease(69) – IIBDGC - http://www.ibdgenetics.org/downloads.html 558 
Coronary artery disease(70) – Cardiogram – http://www.cardiogramplusc4d.org/downloads/  559 
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Figure 1. Genetic correlation matrix across psychiatric phenotypes.  560 
 561 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 562 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 563 
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; 564 
MDD – major depressive disorder; OCD – obsessive-compulsive disorder.  565 
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Figure 2. Genetic correlation matrix across neurological phenotypes.  566 
 567 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 568 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 569 
after Bonferroni correction.  Some phenotypes have substantial overlaps (see Table 1), e.g. all cases of generalized 570 
epilepsy are also cases of epilepsy. Asterisks indicate significant genetic correlation after multiple testing 571 
correction. ICH – intracerebral hemorrhage. 572 
  573 
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Figure 3. Genetic correlation matrix across neurological and psychiatric phenotypes.  574 
 575 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 576 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 577 
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; ICH 578 
– intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-compulsive disorder.  579 
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Figure 4. Genetic correlation matrix across brain disorders and behavioral-cognitive phenotypes.  580 
 581 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 582 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 583 
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; ICH 584 
– intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-compulsive disorder; BMI –585 
body-mass index.  586 
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Table 1. Brain disorder phenotypes used in the Brainstorm project. Indented phenotypes are part of a larger whole, 587 
e.g. the epilepsy study consists of the joint analysis of focal epilepsy and generalized epilepsy. Numbers in gray 588 
denote a sample set which is non-unique, e.g. cardioembolic stroke samples are a subset of ischemic stroke samples. 589 
ADHD – attention deficit hyperactivity disorder; OCD – obsessive-compulsive disorder. ‘Anxiety disorders’ refers 590 
to a meta-analysis of five subtypes (generalized anxiety disorder, panic disorder, social phobia, agoraphobia and 591 
specific phobias). Source details are listed under Data Sources and the references in Table S1. 592 
 593 
 594 
  595 
Psychiatric disorders Neurological disorders
Disorder Source Cases Controls Disorder Source Cases Controls
ADHD PGC-ADD2 12,645 84,435 Alzheimer's disease IGAP 17,008 37,154
Anorexia nervosa PGC-ED 3,495 11,105 Epilepsy ILAE 7,779 20,439
Anxiety disorders ANGST 5,761 11,765    Focal epilepsy " 4,601 17,985
Autism spectrum disorder PGC-AUT 5,305 5,305    Generalized epilepsy " 2,525 16,244
Bipolar disorder PGC-BIP2 20,352 31,358 Intracerebral hemorrhage ISGC 1,545 1,481
Major depressive disorder PGC-MDD2 16,823 25,632 Ischemic stroke METASTROKE 10,307 19,326
OCD PGC-OCDTS 2,936 7,279     Cardioembolic stroke " 1,859 17,708
Schizophrenia PGC-SCZ2 33,640 43,456     Early-onset stroke " 3,274 11,012
Tourette Syndrome PGC-OCDTS 4,220 8,994     Large-vessel disease " 1,817 17,708
    Small-vessel disease " 1,349 17,708
Migraine IHGC 59,673 316,078
   Migraine with aura " 6,332 142,817
   Migraine without aura " 8,348 136,758
Multiple sclerosis IMSGC 5,545 12,153
Parkinson's disease IPDGC 5,333 12,019
Total psychiatric 105,177 229,329 Total neurologic 107,190 418,650
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Table 2. Behavioral-cognitive and additional phenotypes used in the study. Numbers in gray denote overlapping 596 
study sets, e.g. samples in the college attainment analysis are a subset of those in the analysis for years of education. 597 
(d) – dichotomous phenotype, (q) – quantitative phenotype. BMI – body-mass index. Source details are listed under 598 
Data Sources, while references are listed in Table S2.  599 
 600 
 601 
  602 
Phenotype Source Samples
Cognitive
   Years of education (q) SSGAC 293,723
   College attainment (d) " 120,917
   Cognitive performance (q) " 17,989
Personality measures
   Subjective well-being SSGAC 298,420
   Depressive symptoms " 161,460
   Neuroticism (q) " 170,911
   Extraversion (q) GPC 63,030
   Agreeableness (q) " 17,375
   Conscientiousness (q) " 17,375
   Openness (q) " 17,375
Smoking-related
   Never/ever smoked (d) TAG 74,035
   Cigarettes per day (q) TAG 38,617
Additional phenotypes
   BMI (q) GIANT 339,224
   Height (q) " 253,288
   Coronary artery disease (d) Cardiogram 86,995
   Crohn's disease (d) IIBDGC 20,883
Total 1,124,048
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